Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the site's version history.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.2 is now displayed and the previous government funding lapse notice (v3.4.1) has been removed.SummaryDifference0.4%

- Check67 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status; updated to Revision: v3.4.1 (removing Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a Show glossary UI option and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the Revision: v3.4.0 note; these are minor textual and interface changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check88 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4. No changes to study content, eligibility criteria, outcomes, or locations are indicated.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.